March 2017: GnRH analogue as sole luteal support in IVF
Journal Club Global
Ita Bar-Hava, M.D. (Center from A to Z Fertility in Tel Aviv, Israel), and Moran Blueshtein, Ph.D. (UT Dallas), authors of "Gonadotropin-releasing hormone analogue as sole luteal support in antagonist-based assisted reproductive technology cycles," join experts in the field to discuss an alternative approach to luteal support in IVF:
- How can a GnRH agonist provide luteal support for patients undergoing IVF
- What are the advantages and disadvantages of luteal support with intranasal GnRH-a?
- What is the success rate for intranasal GnRH-a luteal support compared to standard progesterone supplementation?
- Can this novel approach to luteal support replace the use of progesterone?
The event is presented by Elizabeth Ginsburg, M.D., and the REI program at Brigham and Women’s Hospital. Expert discussants include Eric Levens, M.D., Valerie Baker, M.D., and Karl Hansen, M.D., Ph.D. The Journal Club Global is hosted by Fertility and Sterility's Video and Media Editor, Kurt Barnhart, M.D., M.S.C.E. at the University of Pennsylvania.
Register to view the discussion here: http://www.workcast.com/register?cpak=5948475532149709